News » Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference

01/10/2022Press Release

Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference

Visby Medical™ announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference.

Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference

SAN JOSE, Calif., Jan. 10, 2022Visby Medical™, a leading medical diagnostic company, today announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference. Visby Founder and CEO Adam de la Zerda, PhD, will present virtually on Thursday, January 13, 2022, at 10:30 a.m. ET. During his presentation, de la Zerda will provide an overview of Visby’s latest developments in hand-held PCR technology, key strategic priorities for 2022 and the future of diagnostics in the age of telemedicine.

The live presentation will be streamed through the J.P. Morgan Healthcare Conference portal, and a recording of the presentation will be available after the event.

About Visby Medical™

Visby Medical is a diagnostics company that is transforming the order of diagnosis and treatment for infectious diseases. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home.

For more information, visit www.visbymedical.com. Follow Visby Medical on LinkedIn; Facebook, and Twitter.

Contact Visby’s Media team for any inquiries: press@visbymedical.com

 

Read more articles & insights

03/14/2023Press Release

Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.

Read More
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

01/03/2023Press Release

Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.

Read More
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

09/15/2022Viewpoint

Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.

Read More
Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

09/14/2022Viewpoint

Visby Medical to Exhibit at ACEP 2022 Scientific Assembly

Join Visby Medical at ACEP 2022, an educational and networking conference hosted by the American College of Emergency Physicians.

Read More
Visby Medical to Exhibit at ACEP 2022 Scientific Assembly